β2-agonists do not work in children under 2 years of age: myth or maxim?

β2-agonists do not work in children under 2 years of age: myth or maxim?

Bibliographic Details
Main Authors:	Fatima Yusuf, Andrew P. Prayle, Michael P. Yanney
Format:	Article
Language:	English
Published:	European Respiratory Society 2019-12-01
Series:	Breathe
Online Access:	http://breathe.ersjournals.com/content/15/4/273.full

Similar Items

Observational Study of Pulse Transit Time in Children With Sleep Disordered Breathing
by: Michael P. Yanney, et al.
Published: (2020-05-01)

Pharmacogenetics of β2-Agonists
by: Nobuyuki Hizawa
Published: (2011-01-01)

Myths and maxims in paediatric respiratory medicine
by: Jayesh M. Bhatt, et al.
Published: (2018-03-01)

Education makes people take their medication: myth or maxim?
by: Ellen M. Driever, et al.
Published: (2020-03-01)

Paradoxical bronchoconstriction caused by β2-adrenoceptor agonists
by: Khadija Ayed, et al.
Published: (2020-10-01)

Agonist-directed desensitization of the β2-adrenergic receptor.
by: Vasiliy Goral, et al.
Published: (2011-04-01)

Effects of β2-agonists and exercise on β2-adrenergic receptor signaling in skeletal muscles
by: Shogo Sato, et al.
Published: (2012-08-01)

Β2-agonist in patients with chronic obstructive pulmonary disease
by: N. N. Mescheryakova
Published: (2014-12-01)

Inhaled β2-agonists in asthma management: an evolving story
by: Diana Silva, et al.
Published: (2016-12-01)

A Selective Pharmacophore Model for β2-Adrenoceptor Agonists
by: Mao-Sheng Cheng, et al.
Published: (2009-11-01)

THE ORIGIN OF «PRESUMPTION OF INNOCENCE» MAXIM: SOME MYTHS DEBUNKING
by: Barabash Anatolii
Published: (2019-12-01)

β2 agonists in athletes. An ergogenic aid? = β2 agonistas en deportistas. ¿Una ayuda ergogénica?
by: Ospina Uribe, Carlos Fernando
Published: (2013-01-01)

BRONCHODILATOR AND TOCOLYTIC FEATURES OF β<sub>2</sub>-ADRENOCEPTOR AGONISTS
by: S. Ya. Skachilova, et al.
Published: (2019-01-01)

Review: Safety of long-acting β2 -agonists in the treatment of asthma
by: Mario Cazzola, et al.
Published: (2007-10-01)

Transdermal Tulobuterol Patch, a Long-Acting β2-Agonist
by: Gen Tamura, et al.
Published: (2012-01-01)

Safety aspect of β2-agonists in chronic obstructive pulmonary disease
by: Whale, Christopher Ian
Published: (2009)

Long-acting β2-adrenergic receptor agonist in pediatric asthma
by: Shigemi Yoshihara, et al.
Published: (2004-01-01)

How β2-adrenergic agonists induce skeletal muscle hypertrophy?
by: Takashi Kitaura
Published: (2013-11-01)

Potential Benefits of Therapeutic Use of β2-Adrenergic Receptor Agonists in Neuroprotection and Parkinson’s Disease
by: Lynda Peterson, et al.
Published: (2014-01-01)

Prolonged stimulation of β2-adrenergic receptor with β2-agonists impairs insulin actions in H9c2 cells
by: Warisara Parichatikanond, et al.
Published: (2018-11-01)

Effects of the β2-Agonist Clenbuterol on β1- and β2-Adrenoceptor mRNA Expressions of Rat Skeletal and Left Ventricle Muscles
by: Shogo Sato, et al.
Published: (2008-01-01)

Effect of Inhaled β2-Agonist on Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease.
by: Mostafa Amer, et al.
Published: (2016-01-01)

β2-agonists promote host defense against bacterial infection in primary human bronchial epithelial cells
by: Weinberger Andrew R, et al.
Published: (2010-05-01)

Physiological function of β-lactotensin, a neurotensin NT2 agonist derived from β-lactoglobulin
by: Yamauchi, Rena
Published: (2011)

Clinical Use of β2-adrenergic Receptor Agonists Based on Their Intrinsic Efficacy
by: Hiroaki Kume
Published: (2005-01-01)

The Effect of β-adrenargic Agonists on Ca^2+ Sensitivity in Tracheal Smooth Muscle
by: Oguma, Tetsuya, et al.
Published: (2003)

Clinical-Pharmacokinetic Aspects of Prolonged Effect Duration as Illustrated by β2-Agonists
by: Rosenborg, Johan
Published: (2001)

Chirality of β2-agonists. An overview of pharmacological activity, stereoselective analysis, and synthesis
by: Ružena Čižmáriková, et al.
Published: (2020-06-01)

Development and Application for the Analysis ofβ2-agonists by FASS-CE/ESI-MS
by: Yi-Ping Yu, et al.
Published: (2014)

Protracted bacterial bronchitis is a precursor for bronchiectasis in children: myth or maxim?
by: Anne B. Chang, et al.
Published: (2019-09-01)

Management of chronic obstructive pulmonary disease: Insights into patient profile – Use of inhaled corticosteroids/long-acting β2-Agonists or long-acting β2-agonists/long-acting muscarinic antagonists
by: Nevin Kishore, et al.
Published: (2020-01-01)

β-blockers Reverse Agonist-Induced β<sub>2</sub>-AR Downregulation Regardless of Their Signaling Profile
by: Sonia Maccari, et al.
Published: (2020-01-01)

Revisiting the Idea That Amyloid-β Peptide Acts as an Agonist for P2X7
by: Lučka Bibič, et al.
Published: (2020-09-01)

Detection of seven β2-agonists in teeth by LC-MS/MS: preliminary results.
by: Maria Nobile, et al.
Published: (2016-06-01)

β2-Agonist Clenbuterol Induced Changes in the Distribution of White Blood Cells in Rats
by: Ken Shirato, et al.
Published: (2007-01-01)

Relaxing action of adrenergic β2-agonists on guinea-pig skinned tracheal muscle
by: Kayo Nemoto, et al.
Published: (1999-01-01)

Reduced suppressive effect of β2-adrenoceptor agonist on fibrocyte function in severe asthma
by: Chun-Yu Lo, et al.
Published: (2017-11-01)

Agonistic Autoantibodies to the β2-Adrenergic Receptor Involved in the Pathogenesis of Open-Angle Glaucoma
by: Anselm Jünemann, et al.
Published: (2018-02-01)

Application of ionic liquid-coating capillary electrophoresis on enantioseparation of flavanones and β2-agonists
by: Jie-Bi Hu, et al.
Published: (2011)

The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan
by: Cheng-Yi Wang, et al.
Published: (2021-04-01)